Sponsored Links
| Study Finds Treatment With Metreleptin Improved Diabetes And Lipid Control In Patients With Partial Lipodystrophy |
 |
 |
 |
| Medical News - Endocrinology | |||
|
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today announced results from a study that showed treatment with metreleptin, an investigational treatment that is an analog of the human hormone leptin, improved diabetes and lipid control in patients with partial lipodystrophy... Read more: Endocrinology News From Medical News Today
|